Current understanding of the toxicological risk posed to the fetus following maternal exposure to nanoparticles

Expert Opin Drug Metab Toxicol. 2017 Dec;13(12):1251-1263. doi: 10.1080/17425255.2018.1397131. Epub 2017 Oct 31.

Abstract

With the broad use of nanotechnology, the number and variety of nanoparticles that humans can be exposed to has further increased. Consequently, there is growing concern about the potential effect of maternal exposure to various nanoparticles during pregnancy on a fetus. However, the nature of this risk is not fully known. Areas covered: In this review, materno-fetal transfer of nanoparticles through the placenta is described. Both prenatal and postnatal adverse effects, such as fetal resorption, malformation and injury to various organs in mice exposed to nanoparticles are reviewed. The potential mechanisms of toxicity are also discussed. Expert opinion: The toxicology and safe application of recently developed nanoparticles has attracted much attention in the past few years. Although many studies have demonstrated the toxicology of nanoparticles in various species, only a small number of studies have examined the effect on a fetus after maternal exposure to nanoparticles. This is particularly important, because the developing fetus is especially vulnerable to the toxic effects of nanoparticles during fetal development due to the unique physical stage of the fetus. Nanoparticles may directly or indirectly impair fetal development and growth after maternal exposure to nanoparticles.

Keywords: Nanoparticles; fetus; mechanism; toxicity; transplacental transfer.

Publication types

  • Review

MeSH terms

  • Animals
  • Female
  • Fetus / drug effects
  • Humans
  • Maternal-Fetal Exchange*
  • Mice
  • Nanoparticles / administration & dosage
  • Nanoparticles / adverse effects*
  • Nanotechnology*
  • Placenta / metabolism
  • Pregnancy
  • Risk
  • Species Specificity
  • Toxicology